Delphine Vandame, PhD, Biocodex, Orphan Disease Division (HQ), Gentilly, France, speaks about key approaches to improve awareness and access in rare epilepsies, such as Dravet syndrome. Her team are trying to improve awareness amongst families and scientific communities to ensure early-stage disease can be identified. For example, they have partnered with Juisci to develop an artificial intelligence-based app which summarizes new publications in the field, enabling the healthcare community to keep up with the literature. Dr Vandame also outlines several projects that aim to reduce the delay in diagnosis and treatment of Dravet syndrome. This interview took place at the International Epilepsy Congress 2023 in Dublin, Ireland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.